DDX21 and neoplasm: Our findings demonstrate that the proper molecular ratio of U3 snoRNA/DDX21 determines mitotic cell fate, and disruption of the molecular balance between U3 snoRNA and DDX21 might provide a potential strategy for tumor therapy through interfering with the PR assembly and causing mitotic catastrophe.